H2 Global Group – Our Story
It has been almost 14 years since David Maršálek accidentally met Professor Dušan Miljkovič in the United States—the man who was the first in the world to introduce a hydrogen-based dietary supplement. This moment marked the beginning of a journey that has since evolved into a project with global ambitions.
Over time, other leading scientists joined the vision—Professor Shigeo Ohta from Japan, Professor Jan Slezák, teams from Palacký University, and additional experts from Europe, the United States, and Japan. This collaboration led to the creation of H2 Global Group, followed later by H2 Medical Technologies, a company dedicated to the research and development of molecular hydrogen in medicine.
From a Single Idea to a Breakthrough Clinical Study
What began as an interest in dietary supplements gradually revealed a much broader potential of molecular hydrogen in medicine, particularly in the field of neurodegenerative diseases. Thanks to an international team of experts, the idea emerged to develop the world’s first medical device based on molecular hydrogen.
And in 2025, a major breakthrough was achieved:
-
The State Institute for Drug Control (SÚKL) approved the first clinical study in the Czech Republic evaluating the safety of molecular hydrogen inhalation in patients with mild cognitive impairment (MCI).
-
The study builds on the successful Japanese research led by Professor Ohta, who is also behind the European patent EP3701956B1, focused on the prevention and therapy of dementia.
A Czech Project with Global Reach
The project is being developed in cooperation with leading scientific teams, including Professor MUDr. David Školoudík and experts from Palacký University. Our vision is to contribute to the medicine of the future, where the primary focus is not only treatment, but above all prevention of civilization-related diseases.
Although we come from a small country, today we possess something truly exceptional:
patents, proprietary technology, and an international team capable of shaping the direction of global medicine.
Full article titled:
Czech Breakthrough in Global Medicine: Molecular Hydrogen Becomes the Focus of the First Clinical Study of Its Kind in the Czech Republic